Otezla and Exforge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Otezla (apremilast) and Exforge (amlodipine besylate; valsartan). Common drug interactions include sepsis among females and psoriasis among males.

The phase IV clinical study analyzes what interactions people have when they take Otezla and Exforge. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Otezla?

Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 146,254 Otezla users. Check the latest studies of Otezla.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

32 people who take Otezla and Exforge together, and have interactions are studied.

Otezla and Exforge drug interactions.

What are the common drug interactions of Otezla and Exforge, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Urinary tract infection
  3. Abdominal discomfort
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Depression
  7. Drug eruption (adverse drug reaction of the skin)
  8. Drug ineffective
  9. Muscle spasms (muscle contraction)
  10. Pain

male:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Abdominal pain upper
  3. Headache (pain in head)
  4. Hepatic fibrosis (scarring process that represents the liver's response to injury)
  5. Nausea (feeling of having an urge to vomit)
  6. Rash

What are the common drug interactions of Otezla and Exforge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Abdominal discomfort
  3. Depression
  4. Diarrhoea
  5. Drug ineffective
  6. Muscle spasms (muscle contraction)
  7. Pain
  8. Gastric infection (infection of stomach)
  9. Hepatic fibrosis (scarring process that represents the liver's response to injury)

60+:

  1. Diarrhoea
  2. Dehydration (dryness resulting from the removal of water)
  3. Fatigue (feeling of tiredness)
  4. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  5. Hypoacusis (loss of hearing)
  6. Neoplasm malignant (cancer tumour)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Rash
  10. Surgery

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 20 people, 62.50%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 43.75%
  3. High Blood Pressure: 5 people, 15.62%
  4. Stress And Anxiety: 2 people, 6.25%
  5. Joint Pain: 2 people, 6.25%
  6. High Blood Cholesterol: 2 people, 6.25%
  7. Diabetes: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Otezla and Exforge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Otezla and Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Otezla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Otezla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apremilast and amlodipine besylate; valsartan (the active ingredients of Otezla and Exforge, respectively), and Otezla and Exforge (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: